[Results of treatment of autoimmune hemolytic anemias].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000628:therapy*; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013156:Splenectomy
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine; D008558:Melphalan; D011241:Prednisone
Wyniki leczenia niedokrwistości autoimmunohemolitycznych.